+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
WOCKPHARMA
₹2,028.40 +68.7 (3.51%)
86.66% Gain from 52W Low

03 Aug, 2026 3:58 PM (IST)

Wockhardt live price: ₹2,028.40. It opened at ₹1,967 vs previous close ₹1,960; intraday high/low: ₹2,035/₹1,941. The 50 & 200 DMA stand at ₹1,846.20/₹1,597.80.

Wockhardt Performance

  • Today's Low
  • ₹1,941
  • Today's High
  • ₹2,035
  • 52 Week Low
  • ₹1,087
  • 52 Week High
  • ₹2,422
  • Open Price₹1,967
  • Previous Close₹1,960
  • Volume1,311,577
  • 50 DMA₹1,846.20
  • 100 DMA₹1,726.00
  • 200 DMA₹1,597.80

Wockhardt Chart

Investment Returns

  • Over 1 Month + 4.02%
  • Over 3 Month + 45.34%
  • Over 6 Month + 54.15%
  • Over 1 Year + 25.8%

Smart Investing Starts Here Start SIP with Wockhardt for Steady Growth!

Invest Now

Wockhardt Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 154.7
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 32,960
  • P/B Ratio
  • 6.7
  • Average True Range
  • 65.6
  • EPS
  • 13.1
  • Dividend Yield
  • 0
  • MACD Signal
  • 18.1
  • RSI
  • 66.73
  • MFI
  • 65.17

Latest Stock News Updates

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed the copies of Newspaper Advertisement published today i.e. 18th July, 2026 in respect to the information regarding the 27th Annual General Meeting (''AGM'') of the Company, Completion of dispatch of Notice of AGM and Annual Report for FY 2026, and Information about remote e-voting and e-voting facility at AGM.

Wockhardt Ltd - 532300 - Business Responsibility and Sustainability Reporting (BRSR)

Please find enclosed the Business Responsibility and Sustainability Report and Independent Assurance Statement on BRSR Core parameters issued by SGS India Private Limited for the Financial Year ended 31st March, 2026.

Wockhardt Ltd - 532300 - Reg. 34 (1) Annual Report.

Please find enclosed herewith the Annual Report of the Company for the Financial Year 2025-26.

Wockhardt Financials

Wockhardt Technicals

EMA & SMA

Current Price
₹2,028.40
+ 68.7 (3.51%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,906.50
  • 50 Day
  • ₹1,846.20
  • 100 Day
  • ₹1,726.00
  • 200 Day
  • ₹1,597.80

Resistance and Support

2001.47 Pivot Speed
  • R3 2,155.90
  • R2 2,095.50
  • R1 2,061.90
  • S1 1,967.90
  • S2 1,907.50
  • S3 1,873.90

Wockhardt Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-04 Audited Results & Others Inter-alia, to consider 1. Raising of funds by issue of Equity Shares, American Depository Receipts , Foreign Currency Convertible Bonds or any combination thereof or any other method.
2026-02-10 Quarterly Results
2025-11-03 Quarterly Results
2025-08-08 Quarterly Results
2025-05-29 Audited Results & Fund Raising

Wockhardt Shareholding Pattern

49.08%
34.44%
7.23%
6.79%
2.47%

About Wockhardt

Wockhardt along with its subsidiaries (the ‘Group’) is a global pharmaceutical and biotech company with presence in UK, Switzerland, Ireland, Russia and many other countries. It has manufacturing and research facilities in India & UK and a manufacturing facility in Ireland and Dubai. The Company has a significant presence in Europe and India. View More
  • NSE Symbol
  • WOCKPHARMA
  • BSE Symbol
  • 532300
  • ISIN
  • INE049B01025

Similar Stocks to Wockhardt

Wockhardt FAQs

Wockhardt share price is ₹2,028 As on 03 August, 2026 | 22:03

The Market Cap of Wockhardt is ₹32959.9 Cr As on 03 August, 2026 | 22:03

The P/E ratio of Wockhardt is 154.7 As on 03 August, 2026 | 22:03

The PB ratio of Wockhardt is 6.7 As on 03 August, 2026 | 22:03

The 52 week High & Low of Wockhardt is ₹2422.3/₹1086.7 respectively As on 03 August, 2026 | 22:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23